Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688016's 5-Year Yield-on-Cost % is ranked better than 94.32% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.31
vs SHSE:688016: 14.12
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shanghai MicroPort Endovascular MedTech (Group) Co 5-Year Yield-on-Cost % Related Terms
SHSE:688016 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Shanghai MicroPort Endovascular MedTech (Group) Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort Endovascular MedTech (Group) Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
Shanghai MicroPort Endovascular MedTech (Group) Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016) has a 5-Year Yield-on-Cost % of 14.12 as of Aug. 18, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai MicroPort Endovascular MedTech (Group) Co and its competitors. This is 97% above median its historical median of 7.17. Over the past decade, Shanghai MicroPort Endovascular MedTech (Group) Co's 5-Year Yield-on-Cost % has ranged from 0.85 to 24.76. According to the industry distribution chart, Shanghai MicroPort Endovascular MedTech (Group) Co ranks #18 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 5.7%.
Is Shanghai MicroPort Endovascular MedTech (Group) Co's 5-Year Yield-on-Cost % too high?
Shanghai MicroPort Endovascular MedTech (Group) Co's current 5-Year Yield-on-Cost % of 14.12 is 97% above median its 10-year median of 7.17. Over the past 10 years, this metric has ranged from a low of 0.85 to a high of 24.76. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.31. Shanghai MicroPort Endovascular MedTech (Group) Co's value of 14.12 is 511.3% above this industry median. Based on the distribution chart, Shanghai MicroPort Endovascular MedTech (Group) Co ranks #18 out of 317 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai MicroPort Endovascular MedTech (Group) Co has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort Endovascular MedTech (Group) Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort Endovascular MedTech (Group) Co ranks #18 out of 317 companies for 5-Year Yield-on-Cost %. This places Shanghai MicroPort Endovascular MedTech (Group) Co in the top 6% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.31. Shanghai MicroPort Endovascular MedTech (Group) Co's value of 14.12 is 511.3% above this benchmark. Historically, Shanghai MicroPort Endovascular MedTech (Group) Co's own 5-Year Yield-on-Cost % has ranged from 0.85 to 24.76 over the past decade. While the company's 10-year median is 7.17 vs. the industry median of 2.31, Shanghai MicroPort Endovascular MedTech (Group) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicroPort Endovascular MedTech (Group) Co's current 5-Year Yield-on-Cost % of 14.12 is 511.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai MicroPort Endovascular MedTech (Group) Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort Endovascular MedTech (Group) Co's current 5-Year Yield-on-Cost % is 14.12, which is 97% above median its own 10-year median of 7.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort Endovascular MedTech (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥123.65, compared to a current price of ¥92.16 — trading 25.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 14.12, which is 97% above median its 10-year median of 7.17 and 511.3% above the Medical Devices & Instruments industry median of 2.31. Shanghai MicroPort Endovascular MedTech (Group) Co's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016), the current 5-Year Yield-on-Cost % is 14.12 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort Endovascular MedTech (Group) Co (SHSE:688016) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort Endovascular MedTech (Group) Co stock appears to be undervalued.
The current stock price of Â¥92.16 is trading 25.5% below its estimated GF Value™ of Â¥123.65.
GuruFocus considers Shanghai MicroPort Endovascular MedTech (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:688016:
5-Year Yield-on-Cost %: 14.12 (97% above median its 10-year median of 7.17)
GF Value™: Â¥123.65 vs. price of Â¥92.16 (25.5% below fair value)
Industry Position: 511.3% above the Medical Devices & Instruments median (#18 of 317)
No single metric tells the full story. See the SHSE:688016 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Microport Endovascular Medtech Co Ltd is engaged in the Research, development, production and sales of interventional medical devices for the aorta and peripheral blood vessels.
96GF Score
Get the complete analysis for SHSE:688016
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688016 has been successfully added to your 
